Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.
Overview
publication date
- August 23, 2013
published in
- The Journal of urology Journal
Research
keywords
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Pyrimidines
- Sulfonamides
Identity
Scopus Document Identifier
- 84888624978
Digital Object Identifier (DOI)
- 10.1016/j.juro.2013.08.043
PubMed ID
- 24209513
Additional Document Info
volume
- 190
issue
- 6